A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
Clinical trial NCT06754644 · RECRUITING
Trial details
- NCT number
- NCT06754644
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2026-12-01
- Enrollment
- 808
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.